LUSTER HIP SZ 3 Packaging: The product was packaged within inner and outer blister trays, sealed...

FDA Device Recall #Z-1917-2012 — Class II — May 16, 2012

Recall Summary

Recall Number Z-1917-2012
Classification Class II — Moderate risk
Date Initiated May 16, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm DePuy Orthopaedics, Inc.
Location Warsaw, IN
Product Type Devices
Quantity (85) LUSTER Cemented Polished Femoral Hip Stems in 69 lots

Product Description

LUSTER HIP SZ 3 Packaging: The product was packaged within inner and outer blister trays, sealed with coated Tyvek lidding. The stems were packaged within vinyl protectors, with foam taper protectors. Intended Use: The LUSTER Cemented Polished Femoral Hip Stems product are forged CoCr polished cemented stems which are used as part of a total hip arthroplasty. These stems were indicated for use with all DePuy bearings and acetabular cups.

Reason for Recall

DePuy Orthopaedics, Inc. is issuing a Field Safety Notice for the LUSTER Cemented Polished Femoral Hip Stems and the ULTIMA LX Cemented Polished Femoral Hip Stems that were implanted with any metal-on-metal (MoM) articulation (including a head of CoCr and an acetabular cup where the cup is of an all metal construction (monoblock or modular)).The LUSTER Cemented Polished Femoral Hip Stems and the U

Distribution Pattern

Nationwide Distribution-including the states of CA, CO, IA, NC, OH, TX, WA, WI, and WV.

Lot / Code Information

Product code:152180003 and Lot numbers: A46D71000, A52C11000, A88D11000, AY2CE1000, B1XGV1000, BA3BF1000, BC6BC1000, BX9B71000, Y97FM1000, and Z5NBJ1000.

Other Recalls from DePuy Orthopaedics, Inc.

Recall # Classification Product Date
Z-1456-2024 Class II ATTUNE AFFIXIUM Cementless Fixed Bearing Knee w... Mar 12, 2024
Z-1264-2023 Class II Attune Revision Limb Preservation System (LPS) ... Feb 15, 2023
Z-1267-2023 Class II Attune Posterior (PS) Fixed Bearing (FB) Tibial... Feb 15, 2023
Z-1263-2023 Class II Attune Revision Limb Preservation System (LPS) ... Feb 15, 2023
Z-1266-2023 Class II Attune Revision Limb Preservation System (LPS) ... Feb 15, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.